Citation Impact

Citing Papers

Exploring pathways linking greenspace to health: Theoretical and methodological guidance
2017 Standout
Critical review of the human data on short-term nitrogen dioxide (NO2) exposures: Evidence for NO2no-effect levels
2009
Selective PDE inhibitors as novel treatments for respiratory diseases
2012
Asthma exacerbations {middle dot} 3: Pathogenesis
2006
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen‐sensitized mice
2008
Exercise induced bronchoconstriction in adults: evidence based diagnosis and management
2016
Environmental and Health Impacts of Air Pollution: A Review
2020 Standout
Acute Asthma in Adults
2004
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Risk and incidence of asthma attributable to occupational exposure among HMO members
1998
Occupational Illness
1995
The effects of outdoor air pollution and tobacco smoke on asthma
2005
Effect of Ozone Exposure on Airway Responses to Inhaled Allergen in Asthmatic Subjects
2004
Human health effects of air pollution
2007 Standout
IgE and mast cells in allergic disease
2012 Standout
Coughing, mucus accumulation, airway obstruction, and airway inflammation in control horses and horses affected with recurrent airway obstruction
2003
Guidelines for the management of work-related asthma
2012
Limited effect of urban tree vegetation on NO2 and O3 concentrations near a traffic route
2014
Toxic Mechanisms of Five Heavy Metals: Mercury, Lead, Chromium, Cadmium, and Arsenic
2021 Standout
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy
2005 Standout
Effects of ozone on lung function and lung diseases
2003
Respiratory Symptoms and Pulmonary Function Testes in Lead Exposed Workers
2012
The effect of air pollution on asthma and allergy
2008
A 6-Month, Placebo-Controlled Study Comparing Lung Function and Health Status Changes in COPD Patients Treated With Tiotropium or Salmeterol
2002
Air pollution: mechanisms of neuroinflammation and CNS disease
2009 Standout
Outdoor air pollution and asthma
2003
Asthma
2017 Standout
Impact of a Soluble Phospholipase A2Inhibitor on Inhaled Allergen Challenge in Subjects with Asthma
2005
Long-acting ?2-agonists in management of childhood asthma: A critical review of the literature
2000
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Asthma
2001 Standout
Fluticasone at different doses for chronic asthma in adults and children
2005
Atmospheric Aerosols: Composition, Transformation, Climate and Health Effects
2005 Standout
Control of Exposure to Mite Allergen and Allergen-Impermeable Bed Covers for Adults with Asthma
2003
Mast Cells in Lung Inflammation
2011
Baseline airway inflammation may be a determinant of the response to ozone exposure in asthmatic patients
2013
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Asthma Control Test (ACT): Comparison with Clinical, Functional, and Biological Markers of Asthma Control
2012
Sarcoidosis
1997 Standout
Health effects of air pollution
2004
Airway Mucus Function and Dysfunction
2010 Standout
Adaptación cultural y validación de cuestionarios de salud: revisión y recomendaciones metodológicas
2013 Standout
Increased Levels of Outdoor Air Pollutants Are Associated With Reduced Bronchodilation in Children With Asthma
2009
Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years
2008
Outdoor air pollution and asthma
2014 Standout
The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies
1998
Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways?
2008
A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force
2001 Standout
The increasing challenge of discovering asthma drugs
2011
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response
2000 Standout
Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes
2010
Airway Subsensitivity with Long-Acting ??2-Agonists Is There Cause for Concern?
1997
Occupational asthma
1998
Effect of Inhaled Interleukin-5 on Airway Hyperreactivity and Eosinophilia in Asthmatics
1998
Occupational Asthma
2005
American Thoracic Society Statement
2003 Standout
Inflammatory Airway Disease of Horses—Revised Consensus Statement
2016 Standout
Induced Sputum Cell Counts in Healthy Adults
2000
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Health Effects of Fine Particulate Air Pollution: Lines that Connect
2006 Standout
Full publication of results initially presented in abstracts
2007 Standout
The Asthma Epidemic
2006 Standout
Personal and Ambient Air Pollution Exposures and Lung Function Decrements in Children with Asthma
2007
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Nanostructuration of PEDOT in Porous Coordination Polymers for Tunable Porosity and Conductivity
2016 StandoutNobel
Design, Synthesis, and Inhibitory Activity of Potent, Photoswitchable Mast Cell Activation Inhibitors
2013 StandoutNobel
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature
2001
Fluticasone at different doses for chronic asthma in adults and children
2008
Fluticasone Propionate Protects against Ozone-Induced Airway Inflammation and Modified Immune Cell Activation Markers in Healthy Volunteers
2008
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
2012
Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation
2018 StandoutNobel

Works of D. Giannini being referenced

Clinical assessment of asthma severity partially corresponds to sputum eosinophilic airway inflammation
2003
Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics.
1994
Short-term effect of the addition of leukotriene receptor antagonists to the current therapy in severe asthmatics
2003
Induced sputum is a reproducible method to assess airway inflammation in asthma
2002
Airway inflammatory response to ozone in subjects with different asthma severity
1999
Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group
1996
Effects of Inhaled Corticosteroids on Cough Threshold in Patients with Bronchial Asthma
2001
Comparison Between Peak Expiratory Flow and Forced Expiratory Volume in One Second (FEV1) During Bronchoconstriction Induced by Different Stimuli
1997
Tolerance to the Protective Effect of Salmeterol on Allergen Challenge Can Be Partially Restored by the Withdrawal of Salmeterol Regular Treatment
2001
Bronchial Hyperresponsiveness and Toluene Diisocyanate
1993
Fifty μg b.i.d. of inhaled fluticasone propionate (FP) are effective in stable asthmatics previously treated with a higher dose of FP
2003
Prognosis of occupational asthma
1994
Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients
2003
Tolerance to the protective effect of salmeterol in mild untreated asthmatics
2003
The Protective Effect of Salbutamol Inhaled Using Different Devices on Methacholine Bronchoconstriction
2000
Reproducibility of early and late asthmatic responses to allergen challenge in a large group of asthmatics
2000
Effect of short-term NO2 exposure on induced sputum in normal, asthmatic and COPD subjects
1996
Budesonide Reduces Neutrophilic but Not Functional Airway Response to Ozone in Mild Asthmatics
2001
Ozone Exposure Increases Eosinophilic Airway Response Induced by Previous Allergen Challenge
2002
Relationship between peak expiratory flow (PEF) and FEV1.
1997
Comparison between hypertonic and isotonic saline‐induced sputum in the evaluation of airway inflammation in subjects with moderate asthma
1996
Leukocyte counts in hypertonic saline-induced sputum in subjects with occupational asthma
1998
Tolerance to the Protective Effect of Salmeterol on Allergen Challenge
1996
Rankless by CCL
2026